Stock 3141 WELCIA HOLDINGS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Welcia Holdings Co., Ltd.

Equities

3141

JP3274280001

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-04-16 am EDT 		5-day change 1st Jan Change
2,284 JPY -1.51% Intraday chart for Welcia Holdings Co., Ltd. -4.15% -7.36%
Apr. 15 Welcia's Attributable Profit Down 2.1% in Fiscal 2024 MT
Feb. 28 Aeon Co. Plans to Merge Japan Drugstore Unit Welcia With Rival Tsuruha -- 2nd Update DJ

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
  • The company's Refinitiv ESG score, based on a relative ranking of the company within its sector, comes out particularly poor.

Strengths

  • The company shows low valuation levels, with an enterprise value at 0.43 times its sales.
  • Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.

Weaknesses

  • The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • The company does not generate enough profits, which is an alarming weak point.
  • The company is not the most generous with respect to shareholders' compensation.
  • The average consensus view of analysts covering the stock has deteriorated over the past four months.
  • Over the past twelve months, analysts' opinions have been revised negatively.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Drug Retailers

1st Jan change Capi. Investor Rating ESG Refinitiv
WELCIA HOLDINGS CO., LTD. Stock Welcia Holdings Co., Ltd.
-7.16% 3.1B
C-
WALGREENS BOOTS ALLIANCE, INC. Stock Walgreens Boots Alliance, Inc.
-32.40% 15.23B
B-
JD HEALTH INTERNATIONAL INC. Stock JD Health International Inc.
-40.15% 9.9B
B
MATSUKIYOCOCOKARA & CO. Stock MatsukiyoCocokara & Co.
-4.21% 6.83B
C+
YIFENG PHARMACY CHAIN CO., LTD. Stock Yifeng Pharmacy Chain Co., Ltd.
+9.14% 6.1B
C
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED Stock Alibaba Health Information Technology Limited
-37.97% 5.59B
B
NAHDI MEDICAL COMPANY Stock Nahdi Medical Company
+5.40% 5B
D-
CORPORATIVO FRAGUA, S.A.B. DE C.V. Stock Corporativo Fragua, S.A.B. de C.V.
+49.08% 4.21B
C
CLICKS GROUP LIMITED Stock Clicks Group Limited
-11.42% 3.65B
B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD. Stock DaShenLin Pharmaceutical Group Co., Ltd.
-11.73% 3.46B
C-
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 3141 Stock
  4. Ratings Welcia Holdings Co., Ltd.